Yi Jer Tan

2.0k total citations · 2 hit papers
24 papers, 1.4k citations indexed

About

Yi Jer Tan is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yi Jer Tan has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Yi Jer Tan's work include Sirtuins and Resveratrol in Medicine (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Insect Pest Control Strategies (3 papers). Yi Jer Tan is often cited by papers focused on Sirtuins and Resveratrol in Medicine (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Insect Pest Control Strategies (3 papers). Yi Jer Tan collaborates with scholars based in China, Malaysia and Australia. Yi Jer Tan's co-authors include Chern Ein Oon, Yeuan Ting Lee, Xiaolan Zhang, Chenyang Li, Chuanling Qiao, Feng Cui, Jia Song, Xiaonan Liang, Shengdian Wang and Marco Falasca and has published in prestigious journals such as The Journal of Immunology, Journal of Hepatology and British Journal of Cancer.

In The Last Decade

Yi Jer Tan

22 papers receiving 1.4k citations

Hit Papers

Molecular targeted therapy: Treating cancer with specificity 2018 2026 2020 2023 2018 2022 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Jer Tan China 13 694 373 260 198 190 24 1.4k
Chenyu Tian China 13 738 1.1× 367 1.0× 172 0.7× 232 1.2× 145 0.8× 24 1.4k
Yeuan Ting Lee Malaysia 6 498 0.7× 300 0.8× 192 0.7× 197 1.0× 85 0.4× 9 1.0k
Melissa Millard United States 14 1.1k 1.6× 298 0.8× 228 0.9× 172 0.9× 151 0.8× 18 1.9k
Raghavendra Gowda United States 20 695 1.0× 248 0.7× 211 0.8× 115 0.6× 165 0.9× 37 1.2k
Yong Zhu China 22 809 1.2× 310 0.8× 314 1.2× 197 1.0× 140 0.7× 70 1.4k
Shuhong Wu China 27 1.1k 1.5× 499 1.3× 307 1.2× 343 1.7× 162 0.9× 81 1.9k
Masanori Okaniwa Japan 16 886 1.3× 229 0.6× 118 0.5× 250 1.3× 236 1.2× 26 1.4k
Marc Abrams United States 22 1.1k 1.6× 281 0.8× 236 0.9× 83 0.4× 163 0.9× 41 1.6k
Prakash Radhakrishnan United States 21 986 1.4× 549 1.5× 429 1.6× 187 0.9× 382 2.0× 47 1.7k
Kanami Yamazaki Japan 17 892 1.3× 334 0.9× 203 0.8× 238 1.2× 67 0.4× 27 1.4k

Countries citing papers authored by Yi Jer Tan

Since Specialization
Citations

This map shows the geographic impact of Yi Jer Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Jer Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Jer Tan more than expected).

Fields of papers citing papers by Yi Jer Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Jer Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Jer Tan. The network helps show where Yi Jer Tan may publish in the future.

Co-authorship network of co-authors of Yi Jer Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Jer Tan. A scholar is included among the top collaborators of Yi Jer Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Jer Tan. Yi Jer Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheng, Yuling, Yan Li, Qi Liu, et al.. (2025). The pronounced cytotoxic effects of chimeric antigen receptor T cells targeting B7-H3 in organoids and liver xenografts derived from colorectal cancer patients. British Journal of Cancer. 133(7). 1056–1065. 1 indexed citations
2.
Lee, Yeuan Ting, Yi Jer Tan, & Chern Ein Oon. (2025). An Overview of Targeted Therapy Applications in Cancer Treatment. 5(1). 30–35.
4.
Tan, Yi Jer, et al.. (2024). Exploring the role of NLRP3 infalmmasome in diabetes: a literature review and bibliometric analysis. Frontiers in Endocrinology. 15. 1443798–1443798. 1 indexed citations
5.
Zhang, Shuxia, Jingnan Huang, Jingyu Yan, et al.. (2024). CPEB1 Controls NRF2 Proteostasis and Ferroptosis Susceptibility in Pancreatic Cancer. International Journal of Biological Sciences. 20(8). 3156–3172. 8 indexed citations
6.
Lee, Yeuan Ting, et al.. (2022). Sex-divergent expression of cytochrome P450 and SIRTUIN 1–7 proteins in toxicity evaluation of a benzimidazole-derived epigenetic modulator in mice. Toxicology and Applied Pharmacology. 445. 116039–116039. 4 indexed citations
7.
Wang, Jing, et al.. (2022). Epidemiology of influenza virus reinfection in Guangxi, China: a retrospective analysis of a nine-year influenza surveillance data. International Journal of Infectious Diseases. 120. 135–141. 11 indexed citations
8.
Lee, Yeuan Ting, Yi Jer Tan, & Chern Ein Oon. (2022). Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine. Acta Pharmaceutica Sinica B. 13(2). 478–497. 155 indexed citations breakdown →
9.
Tan, Yi Jer, Yeuan Ting Lee, Ricardo L. Mancera, & Chern Ein Oon. (2021). BZD9L1 sirtuin inhibitor: Identification of key molecular targets and their biological functions in HCT 116 colorectal cancer cells. Life Sciences. 284. 119747–119747. 7 indexed citations
11.
Tan, Yi Jer, et al.. (2019). Save your gut save your age: The role of the microbiome in stem cell ageing. Journal of Cellular and Molecular Medicine. 23(8). 4866–4875. 20 indexed citations
12.
Lee, Yeuan Ting, Yi Jer Tan, & Chern Ein Oon. (2018). Molecular targeted therapy: Treating cancer with specificity. European Journal of Pharmacology. 834. 188–196. 767 indexed citations breakdown →
13.
Tan, Yi Jer, Yeuan Ting Lee, Keng Yoon Yeong, et al.. (2018). Anticancer Activities of a Benzimidazole Compound Through Sirtuin Inhibition in Colorectal Cancer. Future Medicinal Chemistry. 10(17). 2039–2057. 33 indexed citations
14.
Asif, Muhammad, et al.. (2017). Broad spectrum targeting of tumor vasculature by medicinal plants: An updated review. Journal of Herbal Medicine. 9. 1–13. 14 indexed citations
15.
Tan, Yi Jer, Shukui Qin, Xin Hou, et al.. (2014). Proteomic-based Analysis for Identification of Proteins Involved in 5-fluorouracil Resistance in Hepatocellular Carcinoma. Current Pharmaceutical Design. 20(1). 81–87. 12 indexed citations
16.
Cheng, Liang, Xuexiang Du, Zheng Wang, et al.. (2014). Hyper-IL-15 suppresses metastatic and autochthonous liver cancer by promoting tumour-specific CD8+ T cell responses. Journal of Hepatology. 61(6). 1297–1303. 40 indexed citations
17.
Wu, Xiaoran, Yi Jer Tan, Q. Xing, & Shengdian Wang. (2013). IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation. Protein & Cell. 4(11). 863–871. 8 indexed citations
18.
Cui, Feng, Yi Jer Tan, & Chuanling Qiao. (2007). Filariasis vector in China: insecticide resistance and population structure of mosquito Culex pipiens complex. Pest Management Science. 63(5). 453–458. 18 indexed citations
19.
20.
Alout, Haoués, Arnaud Berthomieu, Feng Cui, et al.. (2007). Different Amino-Acid Substitutions Confer Insecticide Resistance Through Acetylcholinesterase 1 Insensitivity inCulex vishnuiandCulex tritaeniorhynchus(Diptera: Culicidae) from China. Journal of Medical Entomology. 44(3). 463–469. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026